Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study

American Heart Journal

Volumn 153, Issue 1, 2007, Pages 90-97

  Morello, Angela ^a   Lloyd Jones, Donald M ^b   Chae, Claudia U ^a   van Kimmenade, Roland R J ^c   Chen, Annabel C ^a   Baggish, Aaron L ^a   O'Donoghue, Michelle ^a   Lee Lewandrowski, Elizabeth ^a   Januzzi Jr , James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Division of Cardiology ^*  (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS;

EID: 33845293260     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.10.005     Document Type: Article

References (37)

1. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
2. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166 (2006) 315-320
3. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
4. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
5. Altintop L., Yardan T., Cander B., et al. An increase of BNP levels in massive pulmonary embolism and the reduction in response to the acute treatment. Resuscitation 65 (2005) 225-229
6. Ellinor P.T., Low A.F., Patton K.K., et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 45 (2005) 82-86
7. Knudsen C.W., Omland T., Clopton P., et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 46 (2005) 838-844
8. Levey A.S., Berg R.L., Gassman J.J., et al. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 27 (1989) S73-S80
9. O'Donoghue M., Chen A., Baggish A.L., et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 11 5 Suppl (2005) S9-S14
10. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
11. Arima M., Kanoh T., Kawano Y., et al. Plasma levels of brain natriuretic peptide increase in patients with idiopathic bilateral atrial dilatation. Cardiology 97 (2002) 12-17
12. Inoue S., Murakami Y., Sano K., et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6 (2000) 92-96
13. Koitabashi T., Inomata T., Niwano S., et al. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. Int Heart J 46 (2005) 453-464
14. Lee S.H., Jung J.H., Choi S.H., et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70 (2006) 100-104
15. Pozzoli M., Cioffi G., Traversi E., et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
16. Rossi A., Enriquez-Sarano M., Burnett J.C., et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
17. Silvet H., Young-Xu Y., Walleigh D., et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92 (2003) 1124-1127
18. Tsuchida K., and Tanabe K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol 44 (2004) 1-11
19. Nakamura M., Niinuma H., Chiba M., et al. Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Am J Cardiol 79 (1997) 966-970
20. Ohta Y., Shimada T., Yoshitomi H., et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17 (2001) 415-420
21. Vinch C.S., Rashkin J., Logsetty G., et al. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology 102 (2004) 188-1893
22. Watanabe M., Murakami M., Furukawa H., et al. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. J Heart Valve Dis 12 (2003) 287-291
23. Albage A., Kenneback G., van der Linden J., et al. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. Ann Thorac Surg 75 (2003) 790-795
24. Jourdain P., Bellorini M., Funck F., et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 4 (2002) 263-267
25. Mabuchi N., Tsutamoto T., Maeda, et al. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 64 (2000) 765-771
26. Rashidi A. Mechanism of high brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 93 (2004) 670
27. Doyama K., Fukumoto M., Takemura G., et al. Expression and distribution of brain natriuretic peptide in human right atria. J Am Coll Cardiol 32 (1998) 1832-1838
28. Frustaci A., Chimenti C., Bellocci F., et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
29. Nishigaki K., Tomita M., Kagawa K., et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 28 (1996) 1234-1242
30. Tuinenburg A.E., Brundel B.J., Van Gelder I.C., et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 10 (1999) 827-835
31. Beck-da-Silva L., de Bold A., Fraser M., et al. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 20 (2004) 1245-1248
32. Wazni O.M., Martin D.O., Marrouche N.F., et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110 (2004) 124-127
33. O'Toole L., McLean K.A., and Channer K.S. Pulmonary embolism presenting with atrial fibrillation. Lancet 342 (1993) 1050
34. Raggi P., Vasavada B.C., Parente T., et al. Uncommon etiologies of atrial fibrillation. Clin Cardiol 19 (1996) 513-516
35. Pruszczyk P., Kostrubiec M., Bochowicz A., et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 22 (2003) 649-653
36. Pruszczyk P., Szulc M., and Kostrubiec M. Potential clinical application of brain natriuretic peptides in acute pulmonary embolism. Eur Heart J 25 (2004) 621
37. Sohne M., Ten M., and Wolde H.R. Biomarkers in pulmonary embolism. Curr Opin Cardiol 19 (2004) 558-562